Skip to content

Robotic Therapy Early After Stroke Events

Robotic Therapy Early After Stroke Events

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01552733
Acronym
R-TEASE
Enrollment
80
Registered
2012-03-13
Start date
2012-03-01
Completion date
2016-03-16
Last updated
2017-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Brief summary

Weakness and impairment of the upper limb is a common contributing factor to post stroke disability. Specially designed robotic systems have been developed to try to improve this. The investigators already know that their use helps improve limb function after stroke when it has been present for many months. The investigators do not know whether they can help early after stroke and enhance recovery of limb function, and perhaps prevent weakness becoming chronic. The investigators plan a randomised controlled blinded study to explore the benefits of robot assisted therapy early after stroke in 80 stroke survivors. Participants will be randomised by 7 days after stroke to standard care or to robotic therapy (40 participants per study group). Standard of care will be rehabilitation therapy according to local guidelines delivered by NHS multidisciplinary team. Robotic therapy sessions lasts approximately one hour and consists of a series of tasks in first the unimpaired then impaired limb. The robotic-assisted therapy will consist of a series of taks including circle-drawing, reaching targets and holding/moving against moderate resistance. Twelve sessions of therapy within the first 4 weeks after randomisation will be delivered. This study will take 3 years to complete.

Interventions

DEVICE'Inmotion Arm Robot'

To improve limb function in those with limb impairment

OTHERStandard of care

Rehabilitation Therapy

Sponsors

University of Glasgow
CollaboratorOTHER
NHS Greater Glasgow and Clyde
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Aged \> 18 years 2. Confirmed diagnosis of stroke 3. Randomisation by seven days 4. Upper limb impairment, defined as a measurable upper limb impairment on the NIHSS and a baseline upper limb FuglMeyer score of \<50 at randomisation 5. Able to comply with the requirements of the protocol

Exclusion criteria

1. Other significant upper limb impairment e.g. fixed contracture, fracture, frozen shoulder, severe arthritis, amputation. 2. Diagnosis likely to interfere with rehabilitation or outcome assessments such as registered blind or terminal illness. 3. Participation in other stroke rehabilitation trial.

Design outcomes

Primary

MeasureTime frameDescription
Fugl-Meyer score therapy.One month
FeasibilityOne monthDefined as the proportion of individuals randomised to robotic intervention who complete 12 sessions of Robotic therapy. Will serve as a coprimary endpoint.

Secondary

MeasureTime frame
Barthel indexDay 90
Stroke Impact ScaleDay 90
Fugl-Meyer score.Day 90
Action Research Arm TestDay 90
NIHSSDay 90
Modified Rankin scale scoreDAy 90

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026